TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: intrathecal ED50 for motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in eye dryness and related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in lactoferrin levels in tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in vaginal length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POP-Q evaluation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of urine metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rater confidence improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total fracture risk reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Response rates at the end of the acute phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average rate of reduction in BDI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression scores at 10 weeks postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Increase in ventricular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time to re-epithelialisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative health status at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nateglinide area under the concentration-time curve from 0 to 5 hours (AUC(0-5))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to C(max) (T(max))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural delay
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: WMFT mean rate of performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AQLQ total scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: daytime symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of pelvic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to local recurrence or distant metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Involuntary loss of urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severity of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bothersomeness of leakage
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone turnover markers (BAP and NTx) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of enthesitis at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: New-onset enthesitis at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: freedom from acute rejection, graft failure, or death
Endpoint domain: Mortality/survival
Primary endpoint: Rate of PVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of gaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedure time for gap closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of death, myocardial infarction, or coronary revascularization
Endpoint domain: Mortality/survival
Primary endpoint: capsular bag shrinkage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CD4+ and CD20+ cell numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: tissue insufficient for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dilation and curettage (D&C) for abnormal EMB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knowledge about cancer and risk factors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to engage in health-promoting behavior
Endpoint domain: Life impact
Endpoint subdomain: Behavioral intentions
Primary endpoint: Proportion of patients remaining in remission after 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Readmission for febrile neutropenia (FN)
Endpoint domain: Adverse events/effects
Primary endpoint: Complications from early discharge
Endpoint domain: Adverse events/effects
Primary endpoint: stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: renal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Body muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean intensity of vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Attrition rate at 24 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: total knee range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pain while standing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Severity of depression measured by HDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of vaginal birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: actuarial probability of therapeutic failure or relapse
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Postrecurrence survival
Endpoint domain: Mortality/survival
Primary endpoint: steady‐state vestibular evoked myogenic potential (S‐VEMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-km running time trial performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management of Chemotherapy-Induced Nausea and Vomiting (CINV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NNT (Number Needed to Treat)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ICER (Incremental Cost-Effectiveness Ratio)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concentrations of sICAM-1 and sP-Selectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of sexual interest (FSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Beck Depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ISWT duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom-limited exercise test duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ISWT peak heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HBeAg clearance/seroconversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum creatinine at month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Biopsy-proven acute rejection grade 3A
Endpoint domain: Adverse events/effects
Primary endpoint: Intra- and inter-rater correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reoperation rate for infection, wound healing problems, or nonunion
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of cecal preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polyp yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of health plan disenrollment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction with pediatric care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SCORTEN-based predicted mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: skin healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of gastrointestinal hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: 1-year cumulative vaccine efficacy against clinical malaria with matched parasites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 1-year cumulative vaccine efficacy against clinical malaria with mismatched parasites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pad use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mucus leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Respiratory muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of invasive candidiasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Invasive candidiasis-associated mortality rates
Endpoint domain: Mortality/survival
Primary endpoint: WbAg loads reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: GhE loads reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: lifetime history of violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum cephalad dermatome level reached
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Effective duration of the QLB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of affected dermatomes assessed by cold test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of repeat revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence of acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrosis stage at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttransplant diabetes mellitus
Endpoint domain: Adverse events/effects
Primary endpoint: need for blood products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: intensive care unit stays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg cramp distress
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical recovery at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent facial nerve palsy
Endpoint domain: Adverse events/effects
Primary endpoint: Patient preference for InDuo
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived surrogate understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: comfort for patient‐surrogate pairs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: complete motor block of the lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sympathetic block in the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in proportion of lesson time spent in MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphonia Severity Index (DSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fundamental frequency (fo)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice range profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrences and subluxations
Endpoint domain: Adverse events/effects
Primary endpoint: 10 m walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance walked in 3 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgG levels against parasite lysate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Homocysteine levels after methionine load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: transplantation-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Negative Pap smear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance of colposcopic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean amblyopic eye visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet count within targeted range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Death or recurrent infarction within 42 days
Endpoint domain: Mortality/survival
Primary endpoint: need for glaucoma procedure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: need for second IOP medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Gammaglutamyl transferase (GGT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function tests outcomes
Primary endpoint: Alkaline phosphatase (AP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function tests outcomes
Primary endpoint: Total bilirubin (BIL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function tests outcomes
Primary endpoint: Improvement in epigastric pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in postprandial fullness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Interrater reliability of ASA-PS classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postoperative myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Primary combined end-point
Endpoint domain: Mortality/survival
Primary endpoint: Presence of occlusion and stenosis in RA grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Recurrent reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Amount of bending
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean analgesic requirement for paracetamol tablets
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Response rate to omeprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postexercise GH concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postexercise lactate accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: frequency of stroke specific assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: documentation of provision of certain information to patients/carers
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: early discharge notification to general practitioners
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Three-year Distant Metastasis-Free Survival (DMFS)
Endpoint domain: Mortality/survival
Primary endpoint: Grade 3-4 gastrointestinal toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of psychosocial and mental health problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Leukocyte DNA strand breaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum protein concentrations associated with DNA repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volitional activation of hand muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand function restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median duration of abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in depressive and anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attainment of a dry ear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physiological parameters (systolic, diastolic, mean arterial pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quick-Dash score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in T and free-T levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in HOMA index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of patients' distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of relatives' distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for pacing immediately prior to chest closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean costs per patient
Endpoint domain: Resource use
Primary endpoint: Poor outcomes in TB patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily dose of OAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of having a ≥50% response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mean acute monthly MSMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in part B of the Trail Making Test (TMT-B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in part A of the Trail Making Test (TMT-A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of appropriate ICD shocks
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical pregnancy rate per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of participants with excellent CPR performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coincidence anticipation timing performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Postdilation increase in IOP of ≥ 5 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Postdilation increase in IOP of ≥ 8 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Postdilation IOP of >25 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Nocturnal arterial carbon dioxide tension (Paco(2))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Daily use of NPPV
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CL/F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total respiratory disturbance index (RDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: supine RDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: arousal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Jaundice index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Danger Assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of the intervention measured by objective structured clinical examination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate counseling skills achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-assessment of cessation skills and students' satisfaction with training
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knee-joint pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Index of severity of osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes